August 9, 2019
Otsuka President Tatsuo Higuchi Otsuka Holdings’ pharmaceutical revenue in January-June climbed nearly 13% year on year thanks to buoyant performances from four global brands, particularly Jynarque (tolvaptan), which gained US approval last year as the first treatment for a rare...read more